Skip to main content

CureVac shares tank 50% after preliminary data shows Covid vaccine is only 47% effective

The late-stage clinical trial found high prevalence of virus variants.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.